This study is randomized, clinical trial,singlecenter and double-blind for patients and researchers. The aim of this study is to evaluate the effects of treatment with vitamin D on antioxidant capacity and ADHD symptoms in Students 6-13 years with ADHD that is controling by Placebo. Inclusion criteria: Age group participants is 6-13 years; Non-having other chronic diseases; Lack of consumption of Vitamin D supplementation from two months before the intervention; Lack of consumption of Selenium, Calcium, Vitamin C ,Vitamin E, Omega3 and Zinc supplementations from one month before the intervention. Exclusion criteria:The use of methods such as Neurofeedback, Play-therapy and parenting education during the intervention; nonconsent of parents for the continued cooperation During the study. Sample of the study includes 84 of Patients(42 patients in the Vitamin D group and 42 patients in the Pelasibo group) . The intervention group consume 1000 IU of Vitamin D3 daily for 12 weeks and control group in the same period, consume Placebo. ADHD symptoms in both groups, with the score SDQ (Strengths and Difficulties Questionnaire), CPQ(Conners Parent Questionnaire) and CPT(Continue performances Test) are evaluated before and after the intervention. 25(OH) vitamin D , total Antioxidant Capacity, Malon Di Aldehyde, Glutathione and Catalase of participants serum in two groups before and after intervention measured by Elisa and Spectrophotometry metods.